Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Richard, Pratley"'
Autor:
Stefano Del Prato, Zhuoru Li, Chinthanie Ramasundarahettige, Kelley R. H. Branch, Carolyn S. P. Lam, Renato D. Lopes, Richard Pratley, Julio Rosenstock, Naveed Sattar, Hertzel C. Gerstein
Publikováno v:
Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-7 (2024)
Abstract Aims To estimate the incidence of major adverse cardiovascular events (MACE), expanded MACE, and MACE or Death across Fibrosis- 4 score (FIB-4) categories in people with type 2 diabetes and to determine whether efpeglenatide’s effect varie
Externí odkaz:
https://doaj.org/article/5aca8709d53749818d134c8d95f3c546
Autor:
Sangeeta R. Kashyap, Cyrus Desouza, Vanita R. Aroda, Sun H. Kim, Lisa M. Neff, Shannon S. Wu, Philip Raskin, Richard Pratley
Publikováno v:
American Journal of Preventive Cardiology, Vol 15, Iss , Pp 100525- (2023)
Objectives: Prediabetes represents a spectrum of metabolic abnormalities, including insulin resistance and secretory impairment, that carries increased cardiovascular disease (CVD) risk. It is unclear whether specific glycemic and metabolic sub-class
Externí odkaz:
https://doaj.org/article/f5ed81aad79c485488993c6bb0d8a7a8
Autor:
Lauren E. Dang, Susan Gruber, Hana Lee, Issa J. Dahabreh, Elizabeth A. Stuart, Brian D. Williamson, Richard Wyss, Iván Díaz, Debashis Ghosh, Emre Kıcıman, Demissie Alemayehu, Katherine L. Hoffman, Carla Y. Vossen, Raymond A. Huml, Henrik Ravn, Kajsa Kvist, Richard Pratley, Mei-Chiung Shih, Gene Pennello, David Martin, Salina P. Waddy, Charles E. Barr, Mouna Akacha, John B. Buse, Mark van der Laan, Maya Petersen
Publikováno v:
Journal of Clinical and Translational Science, Vol 7 (2023)
Increasing emphasis on the use of real-world evidence (RWE) to support clinical policy and regulatory decision-making has led to a proliferation of guidance, advice, and frameworks from regulatory agencies, academia, professional societies, and indus
Externí odkaz:
https://doaj.org/article/1b066ab2c2c342e3b214a06e4b384ce1
Provides a comprehensive manual encompassing a multitude of topics that forms an invaluable aide-memoire for practitioners and students alike. It guides the reader through the complex maze of demands to achieve a successful contract and is the perfec
Autor:
Eduardo Oliveira, Amay Parikh, Arnaldo Lopez-Ruiz, Maria Carrilo, Joshua Goldberg, Martin Cearras, Khaled Fernainy, Sonja Andersen, Luis Mercado, Jian Guan, Hammad Zafar, Patricia Louzon, Amy Carr, Natasha Baloch, Richard Pratley, Scott Silverstry, Vincent Hsu, Jason Sniffen, Victor Herrera, Neil Finkler
Publikováno v:
PLoS ONE, Vol 16, Iss 3, p e0249038 (2021)
BackgroundObservational studies have consistently described poor clinical outcomes and increased ICU mortality in patients with severe coronavirus disease 2019 (COVID-19) who require mechanical ventilation (MV). Our study describes the clinical chara
Externí odkaz:
https://doaj.org/article/473a1f7b176145c99d82759740e2fda5
Autor:
Anna R Kahkoska, John A. Batsis, Michael R. Kosorok, Elizabeth J. Mayer-Davis, Richard Pratley, Ruth Weinstock, Laura A. Young, Kristen Hassmiller Lich
Publikováno v:
Journal of Clinical and Translational Science, Vol 6, Pp 67-67 (2022)
OBJECTIVES/GOALS: As the number of older adults (≥65 years) with T1D grows, there are limited data to guide care. In a six-month trial, CGM reduced hypoglycemia in older adults, yet there are challenges for widespread uptake. Our objective is t
Externí odkaz:
https://doaj.org/article/b9e5e04feaab4f1c9602b9e843e6aa10
Autor:
Hertzel C. Gerstein, Zhuoru Li, Chinthanie Ramasundarahettige, Seungjae Baek, Kelley R.H. Branch, Stefano Del Prato, Carolyn S.P. Lam, Renato D. Lopes, Richard Pratley, Julio Rosenstock, Naveed Sattar
Publikováno v:
Circulation. 147:1004-1013
Background: In the AMPLITUDE-O (Effect of Efpeglenatide on Cardiovascular Outcomes) cardiovascular outcomes trial, adding either 4 mg or 6 mg weekly of the glucagon-like peptide-1 receptor agonist efpeglenatide to usual care reduced major adverse car
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::75febf460d35be68529cc5a3b270099e
https://doi.org/10.1161/circulationaha.122.063716
https://doi.org/10.1161/circulationaha.122.063716
Autor:
Vanita R. Aroda, Umut Erhan, Peter Jelnes, Juris J. Meier, Morten Tind Abildlund, Richard Pratley, Tina Vilsbøll, Mansoor Husain
Publikováno v:
Diabetes, Obesity and Metabolism. 25:1385-1397
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::485b6f3c2f38e7ad642793d142491f15
https://doi.org/10.1111/dom.14990
https://doi.org/10.1111/dom.14990
Autor:
Chhavi Chadha, Anastassios G. Pittas, Christine W. Lary, William C. Knowler, Ranee Chatterjee, Lawrence S. Phillips, Vanita R. Aroda, Michael R. Lewis, Richard Pratley, Myrlene A. Staten, Jason Nelson, Neda Rasouli, Irwin Brodsky
Publikováno v:
Metabolism Open, Vol 6, Iss , Pp 100031- (2020)
Aims: To assess whether meeting both fasting plasma glucose (FPG) and HbA1c criteria for prediabetes in people at high risk indicates with near certainty the presence of dysglycemia on repeat testing. Methods: Observational study using data from Vita
Externí odkaz:
https://doaj.org/article/0b41e4074a8a4235baf6cedc6c866c25
Autor:
Sun H Kim, Ipsa Arora, Daniel S Hsia, William C Knowler, Erin LeBlanc, Eleftherios Mylonakis, Richard Pratley, Anastassios G Pittas
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism.
There is evidence suggesting that infection with SARS-CoV-2 can lead to several long-term sequelae including diabetes. This mini-review examines the rapidly evolving and conflicting literature on new-onset diabetes after COVID-19, which we term NODAC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ae419b14a55bf060aeb9f53abe4d5866
https://doi.org/10.1210/clinem/dgad284
https://doi.org/10.1210/clinem/dgad284